It is worth noting that PVR, NECTIN2 have a low correlation with immune checkpoint receptors in tumors, which may be due to the almost non-existent expression of PVR and NECTIN2 on immune cells (Figure 7) and explain the beneficial role of low expression of PVR, NECTIN2 in tumor survival assays. Here, NECTIN2 is linked to neoplasm.